Board of Directors

Home » About CureSearch » Board of Directors

CureSearch Directors provide outstanding executive leadership, experience and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today.

Chair of the Board

Jared Brancazio, WMS®
Currently VP, Investments at Brancazio Wealth Management of Raymond James, Mr. Brancazio has spent more than 20 years in high level finance and investment roles and has also served in key volunteer leadership roles at organizations including the Leukemia & Lymphoma Society, Florida Cancer Specialists Foundation and Florida Southwestern State College Foundation. Mr. Brancazio, himself a cancer survivor, previously served as Board Treasurer.

Secretary

Suzanne Finnegan

Suzanne Finnegan
Director & Chief Credit Officer at Build America Mutual

Assurance Company

Treasurer

Trent Demulling

Trent Demulling
Chief Financial Officer at Kiewit

Members

Ali Frost

Ali Frost
Vice-Chair, Marketing Committee
CMO at Ship Sticks

Annie Gould

Annie Gould
Nominating Committee
Childhood Cancer Advocate
Barboursville, VA

Brenda Weigel

Brenda Weigel, MD
Chair, Scientific Advisory Council

Director, Division of Pediatric Hematology/Oncology at

University of Minnesota

Cason Carter

Cason Carter
Strategy Oversight Committee
Director, Head of Public Affairs at Citadel, LLC

Cherry Trivedi

Cherry Trivedi
Audit Committee

CEO at Ayuroma Advisory International

Dave Kupiec

Dave Kupiec
Chair, Marketing Committee

CEO/Founder at KPI Media Partners

Dave Whan

Dave Whan
Development Committee

VP, People & Culture at Federal Reserve Bank of St. Louis

Hank Adams

Hank Adams
Chair, Nominating Committee

Executive Vice President & Division Manager at Kiewit

Jeffrey Skolnik

Jeffrey Skolnik
Chair, Industry Advisory Council

Senior Vice President of Clinical Development at Inovio

Kathy Wanner

Kathy Wanner
Founding Partner at Fairway Capital Management

Mike Miller

Mike Miller, Esquire
Emeritus, Board of Directors
Senior Council at Fisher & Phillips, LLP

Placeholder

Paula and Mike Carter
Co-Founders, Scott Carter Foundation

Sam Blackman

Sam Blackman, MD, PhD
Strategy Oversight Committee

Co-Founder & Chief Medical Officer
at Day One Biopharmaceuticals

Shari Collier

Shari Collier
CureSearch Audit Chair

Division CFO at St. David's HealthCare

Shari Collier (1)

Stacey Adam, PhD
Chair, Strategy Oversight Committee
Director of Cancer Research Partnerships at FNIH

Stu Siegel

Stu E. Siegel, MD
Chair Emeritus, Board of Directors

Retired Director at Children's

Hospital Los Angeles

Tina Swallow

Tina Swallow
Development Committee

Sales Director, DoD at

Trellix

Strategy Oversight Committee

The Strategy Oversight Committee fosters a cooperative, interactive strategic planning process between the Board and management.

Stacey Adam, PhD, Chair
Associate Vice President, Research Partnerships
Foundation for the National Institutes of Health

Members

Cason Carter
Director, Head of Public Affairs
Citadel, LLC

Samuel C. Blackman, MD, PhD,
Co-founder & Chief Medical Officer
Day One Biopharmaceuticals

Kathy Wanner
Operating Partner
Abundant Venture Partners

Syril Petit
Executive Director
Health and Environmental Sciences Institute (HESI)

Chris Lee
Managing Director, Strategy & Corporate Development
Palladium

Gordon Cohen
Global Clinical Head

Lou Stancato, PhD
VP of Enabling Technologies and Global Leader of the Pediatric Rare Disease Platform
Indiana Biosciences Research Institute

Pin It on Pinterest

Scroll to Top